Global Digital Therapeutics Market

Digital Therapeutics Market Size, Share, Growth Analysis, By Offering (software/platforms, programs, virtual reality/games), By revenue model (subscription-based model, one-time purchase/annual licensing model, and outcome /value-based model), By application (treatment/care-related applications, and preventive applications), By distribution channel (B2B sales channel, and B2C sales channel), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35G2136 | Region: Global | Published Date: September, 2024
Pages: 274 | Tables: 119 | Figures: 77

Digital Therapeutics Market News

  • In May 2024, Otsuka announced the introduction of their subsidiary focusing on data and technology. The Otsuka Precision Health will commercialize Rejoyn, which is a digital therapeutic for people suffering from major depressive disorder. 
  • In January 2024, Eli Lilly and Company introduced their LillyDirect. It is a digital healthcare platform for U.S. patients that can manage obesity, migraine, and diabetes.  
  • In November 2023, Curavit Clinical Research launched a new service for clinical trials. This service emphasizes Health Economics and Outcomes Research (HEOR). 
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Digital Therapeutics Market size was valued at USD 3.44 billion in 2022 and is poised to grow from USD 4.01 billion in 2023 to USD 13.72 billion by 2031, at a CAGR of 16.61 % during the forecast period (2024-2031).

The digital therapeutics market is a dynamic and fragmented market. It consists of many players in digital therapeutics who offer a wide range of products, like mobile software and devices. Market leader Pear Therapeutics, Inc, is dominating the market with a strong line of software. The growing sales of reSET & reSET-O in the U.S. are supporting its strong market share. Furthermore, the increasing investments in research and development of digital therapeutics products is also contributing towards the expansion of the market globally. 'ANSYS (US) ', 'Dassault Systèmes (SIMULIA) (France) ', 'Siemens Digital Industries Software (Simcenter) (Germany) ', 'PTC (Creo) (US) ', 'Autodesk (Simulation) (US) ', 'OpenFOAM (Open-source) (N/A) ', 'STAR-CCM+ (US/Germany) ', 'COMSOL Multiphysics (Sweden) ', 'CD-adapco (STAR-CD, STAR-CCM+) (US/Germany) ', 'Altair (HyperWorks) (US) ', 'ESI Group (France) ', 'MSC Software (MSC Adams, MSC Marc) (US) ', 'MathWorks (MATLAB/Simulink) (US) ', 'Flow3D (US) ', 'Fluent (acquired by ANSYS) (US) ', 'CONVECTION (US) ', 'Cadence Design Systems (US) ', 'Synopsys (US) ', 'Numerica (US) ', 'Pointwise (US)'

The demand for therapeutics software and devices is increasing because of the management and treatment of chronic diseases globally. Furthermore, the incidences of chronic conditions, like type 1 diabetes & type 2 diabetes, cancers, Alzheimer’s diseases, obesity, and gastrointestinal disorders are also increasing. This is especially true in emerging economies, which is propelling the demand for this software during the forecast period.  

Incorporation of Digital Therapeutics with Healthcare Systems: Digital therapeutics can be smoothly incorporated into electronic health records (EHRs) and other healthcare systems. This helps medical professionals to easily access and monitor patient data in real-time. This restructuring of medical delivery enhances the efficiency of care and helps doctors to make better and more informed decisions. Furthermore, incorporation with medical systems also improves security and standardizes data sharing between digital therapeutics platforms and medical professionals.  

North America is dominating the digital therapeutics market with the largest revenue share. This is mainly due to the increasing number of initiatives for reducing the rising healthcare spending across the region. Furthermore, the region is a hub for many solutions providers for digital therapeutics that again drive the region's market growth. The digital therapeutics market expansion in this region is fueled by factors such as the entry of new startups, changes in the reimbursement structure of digital therapeutics, increased investments in digital therapeutics, and growing government initiatives to assist technological developments.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Digital Therapeutics Market

Report ID: SQMIG35G2136

$5,300
BUY NOW GET FREE SAMPLE